Cargando…
The epidemiology of acquired demyelinating syndrome in children: a complex opportunity to investigate the etiopathogenesis of multiple sclerosis
This commentary is on the original article by Abdel‐Mannan et al. on pages 502–508 of this issue.
Autores principales: | Pugliatti, Maura, Ferri, Caterina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9300026/ https://www.ncbi.nlm.nih.gov/pubmed/34904715 http://dx.doi.org/10.1111/dmcn.15119 |
Ejemplares similares
-
The Role of Microorganisms in the Etiopathogenesis of Demyelinating Diseases
por: Frau, Jessica, et al.
Publicado: (2023) -
Gut Microbiota Changes during Dimethyl Fumarate Treatment in Patients with Multiple Sclerosis
por: Ferri, Caterina, et al.
Publicado: (2023) -
Demyelination in multiple sclerosis
por: Lubetzki, Catherine, et al.
Publicado: (2014) -
Dimethyl Fumarate Treatment Reduces the Amount but Not the Avidity of the Epstein–Barr Virus Capsid-Antigen-Specific Antibody Response in Multiple Sclerosis: A Pilot Study
por: Castellazzi, Massimiliano, et al.
Publicado: (2023) -
Editorial: Etiopathogenesis of Systemic Sclerosis: An Update
por: Stifano, Giuseppina, et al.
Publicado: (2021)